Navigation Links
RNL BIO Co. Ltd. stellt IND-Antrag, um klinische Phase-II-Studie des RNL-JointStem gegen Arthrose in den Vereinigten Staaten einzuleiten
Date:5/3/2013

ssiv zu Lähmungen führt, in erster Linie den Knorpel befällt und mit Veränderungen des Knochens verbunden ist. Knorpel verfügt über eine eingeschränkte intrinsische Heil- und Regenerationsfähigkeit.

Mit dieser Studie

Aufgrund der steigenden Inzidenz degenerativer Arthritis, der alternden Bevölkerung und der ineffizienten Therapieoptionen sind neue Strategien zum Knorpelaufbau erforderlich. Der Markt für ein therapeutisch wirksames Produkt für diese Indikation ist Schätzungen zufolge sehr groß.

Informationen zu IND-Anträgen

Der IND-Antrag (Investigational New Drug) ist Teil eines Zulassungsverfahrens zur Durchführung klinischer Untersuchungen in den Vereinigten Staaten. Ein IND-Antrag ist immer dann erforderlich, wenn die Durchführung einer klinischen Untersuchung in den Vereinigten Staaten beabsichtigt wird. Ein IND-Antrag enthält Informationen über die Qualität, Herstellung und Kontrolle eines Arzneimittelkandidaten sowie Daten aus präklinischen Studien und Angaben bezüglich des beabsichtigten Einsatzzwecks. Eine grundsätzliche Nutzen-Risiko-Bewertung sowie kritische Analysen präklinischer Daten unter Berücksichtigung aller potenziellen Risiken und Vorteile der vorgeschlagenen Studie müssen ebenfalls Teil des IND-Antrags sein.

Informationen zu klinischen Phase-II-Studien

Studien an klinischen Interventionen auf Basis von Biologika, wozu auch autologe, aus menschlichem Fett gewonnene Stammzellen gehören, unterliegen strengsten Kontrollen des Center for Biologics Evaluation and Research (CBER) der FDA. Nachdem das CBER und das örtliche Institutional Review Board (IRB) den Arzneimittelkandidaten für akzeptabel befunden haben, besteht die FDA auf die Durchführung einer Reihe mehrstufiger klinischer Studien. In Phase I ste
'/>"/>

SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Taiho Pharmaceutical stellt Zulassungsantrag zur Herstellung und Vermarktung des neuartigen Antitumormittels TAS-102
2. Dr. Joachim Schorr (PhD) zum Chief Scientific Officer von Caris Life Sciences bestellt
3. Harvest Technologies Corporation erhält CE-Kennzeichnung für erweiterte klinische Indikation zur Behandlung nicht optionaler kritischer Extremitätenischämie
4. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
5. IDEV gibt Ergebnisse von Studie zur Revaskularisation mit Supera an echten Patienten (RESTORE) bekannt - Studie demonstriert positive klinische Ergebnisse bei schwerkranken Patienten mit langen Läsionen
6. Neue klinische Richtlinien für ältere Patienten mit Typ 2 Diabetes, um einen europaweiten Pflegenotstand zu verhindern
7. MR Solutions bringt vollständige Reihe heliumfreier präklinischer Magnetresonanztomographen auf den Markt
8. Neuartige Krebsimmuntherapie für den Beginn klinischer Studien bereit
9. Acutus Medical, Inc. erprobt erstmals seinen Echtzeit-3D-Bildgebungskatheter von CT/MRI-Qualität in einer klinischen Studie am Menschen
10. RNL BIO Co. Ltd. Files IND To Commence Phase II Clinical Trial Of RNL-JointStem For Osteoarthritis In The United States
11. RNL BIO Co. Ltd. lämnar in IND-ansökan om att påbörja klinisk fas II-prövning av RNL-JointStem för artros i USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical ... proprietary products to treat voiding dysfunctions, will host ... March 12, 2015, beginning at 3:00 pm Central ... Minnetonka , Minnesota.     Rob ... host the meeting, which will feature a discussion ...
(Date:3/3/2015)... March 3, 2015 Although lung cancer is ... there are only 18 drugs in the market for ... Avastin are nearing their patent expiry in 2015 and ... offers vast potential that drug manufacturers are vying to ... small cell lung cancer (SCLC) and non-small cell lung ...
(Date:3/3/2015)... March 3, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") ... , Chief Executive Officer of ImmunoCellular, will present a ... Annual ROTH Conference on Tuesday, March 10, 2014 ... Laguna Niguel , CA.   ... presentation, please log on through a link located in ...
Breaking Medicine Technology:Uroplasty to Host Investor Meeting at Corporate Headquarters 2Uroplasty to Host Investor Meeting at Corporate Headquarters 3Uroplasty to Host Investor Meeting at Corporate Headquarters 4Uroplasty to Host Investor Meeting at Corporate Headquarters 5Uroplasty to Host Investor Meeting at Corporate Headquarters 6Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 2Targeted Lung Cancer Therapies Are Supplanting Conventional Treatments 3ImmunoCellular Therapeutics to Present at ROTH Conference on March 10th 2
... , CAMBRIDGE, Mass., Nov. 19 Ligon Discovery, Inc., ... drugs against high-value targets, today announced that it has ... The company will use the capital to complete its ... disease protein targets. With this investment, incTANK Ventures General ...
... , NEWPORT NEWS, Va., Nov. 19 Breast-Specific Gamma ... by two highly esteemed organizations for the fight against ... the American College of Surgeons. Both societies published articles ... for the early detection of breast cancer. , "These ...
Cached Medicine Technology:Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3
(Date:3/3/2015)... Fremont, California (PRWEB) March 03, 2015 ... remote access connectivity solutions, today announced the global ... (CESA 2.0). It delivers the world’s most deployed ... Microsoft Windows® Server 2012 R2. This new release ... R2 remote access platform from a single HTML ...
(Date:3/3/2015)... Auckland, New Zealand and Rockville, Maryland (PRWEB) March ... has selected Cornerstone Communications, LTD as its North ... record. Cornerstone was awarded the Manuka Lab contract ... beauty, and consumer verticals. , Headquartered in Auckland, ... private company focused on providing clients effective, certified ...
(Date:3/3/2015)... March 03, 2015 Venato, a ... announced that their flagship software solution now provides ... to be uploaded to the National Healthcare Safety ... Medicaid Services (CMS) require that hospitals submit healthcare ... no later than May 15 for each influenza ...
(Date:3/3/2015)... Raritan Bay Medical Center is proud to ... photo contest held at the Woodbridge Center Mall in ... awareness for health and wellness in the Central New ... health and wellness tips. , Photos of visitors sharing ... and Facebook page where Facebook users voted on their ...
(Date:3/3/2015)... 2015 Nutritional supplement e-tailer PureFormulas ... presenter at the third ecommerce Conference and Expo, ... Exhibition Centre March 10-12. , PureFormulas CMO Daniel ... 11 am (Melbourne time). His session, entitled “Tapping ... making each customer’s experience unique via personalization, as ...
Breaking Medicine News(10 mins):Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3Health News:Manuka Lab North America, Inc. Awards Cornerstone Communications, LTD North American Agency Contract 2Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:Raritan Bay Medical Center Announces Winners of “Picture of Health” Photo Contest 2Health News:South Florida-based PureFormulas will discuss personalization at ecommerce Conference and Expo in Melbourne, Australia 2
... YORK, March 21 Haymarket Media Inc. is ... clinicians, The American,Journal of Hematology/Oncology and Oncology Nursing ... previously published by U.S.,HealthCare Communications, of Highland Park, ... a strong oncology presence to the Haymarket,clinical family," ...
... 21 In two weeks, on April,4, 2008, Deerfield Spa ... spa discounts. During the ten-day periods of April 4 to ... days for the price of one,week and receive a $70 ... in between -- from April 13 to 18, 2008 --,Deerfield ...
... increase in personal problems among adolescents with persistent sleeplessness, ... Science Center at Houston say they have completed the ... insomnia on 11 to 17 year olds. More than ... more symptoms of insomnia and almost half of these ...
... March 21 MEDai, Inc., headquartered in,Orlando, FL, ... that,utilize award-winning predictive analytics, has been helping health ... of predictive modeling.,At the upcoming World Research Group ... present a general session and,workshop that helps organizations ...
... recent survey by the Harvard School of Public Health (HSPH) ... Health: Election 2008, finds that Americans are generally split on ... health care system in the world (45% believe the U.S. ... systems; 15% dont know or refused to answer) and that ...
... bacteria in the blood , In developed ... usually occurs through eating contaminated food and causes gastroenteritis. ... 2 and HIV-infected adults usually develop an infection in ... quarter of affected children. There is currently no vaccine ...
Cached Medicine News:Health News:Haymarket Adds Two Cancer Journals to Its Family of Clinical Publications 2Health News:Deerfield Spa, Voted Among 'Best Affordable Spas,' Opens 2008 Season With Discounts, Savings, Gifts, Specials 2Health News:Adolescents with chronic insomnia report 'twofold to fivefold' increase in personal problems 2Health News:MEDai Assists Healthcare Organizations Demonstrate the Value of Predictive Modeling 2Health News:Most republicans think the US health care system is the best in the world; democrats disagree 2Health News:Most republicans think the US health care system is the best in the world; democrats disagree 3Health News:JCI table of contents: March 20, 2008 2Health News:JCI table of contents: March 20, 2008 3Health News:JCI table of contents: March 20, 2008 4Health News:JCI table of contents: March 20, 2008 5
... The PowerPac HV high-voltage ... V, supports an increased output ... and 400 W. Built-in infrared ... transfer. Power cord and instructions ...
... free flowing powder EEO(-m r ): less than ... than or equal to 31C Remelt Point (3%): ... greater than or equal to 500 gm/cm 2 ... gm/cm 2 Moisture: less than or equal to ...
... SPECIFICATIONS Form: Granular, free-flowing powder EEO(-m r ): ... less than or equal to 35.5C Remelt Point ... Strength (1.5%): greater than or equal to 600 ... than or equal to 1500 gm/cm 2 Moisture: ...
... 5000 mg/kg sulfate (SO 4 ) ≤ 5000 mg/kg ... mg/kg Co ≤ 5 mg/kg Cr ≤ 5 mg/kg ... ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ≤ ... mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 mg/kg ...
Medicine Products: